Estimate Recalculated Dec 11, 2024 12:01AM EST
Julie Smith has an estimated net worth of $1.64 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., Stoke Therapeutics, Inc., Audentes Therapeutics, Inc., and Raptor Pharmaceutical Corp.
Julie Smith's CIK is 0001557928
2016 was Julie Smith's most active year for acquiring shares with 4 total transactions. Julie Smith's most active month to acquire stocks was the month of April. 2016 was Julie Smith's most active year for disposing of shares, totalling 5 transactions. Julie Smith's most active month to dispose stocks was the month of September. 2014 saw Julie Smith paying a total of $199,996.50 for 320,015 shares, this is the most they've acquired in one year. In 2016 Julie Smith cashed out on 677,583 shares for a total of $989,442.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!